Current Location:
Became a manufacturer of cytokines, growth factors, IVD raw materials and industry enzymes
Increasing investment in research and development to provide customers with better products and services
Established in Nantong and began to build a basic platform of bio-innovative drugs
Raised tens of millions of funds and the revenue exceeded 100 million RMB for the first time
2022 to present